EUVIMEDEUVIMED entdecken
Crossref

Association between pan-immune-inflammation value and mortality in osteoarthritis: evidence for elevated risk at higher levels

Donghai Wang, Fang Li, Yantong Liu, Shixuan Wang iD

Modern Rheumatology · 04.11.2026 · 36 (6) · 1055-1065

DOI: 10.1093/mr/roag038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Rheumatology, online erschienen am 08.05.2026. Verfasst von Donghai Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Liaoning University of Traditional Chinese Medicine, The Second Clinical College, Shenyang, China. Hauptthemen laut MEDLINE: Osteoarthritis, Inflammation, Cardiovascular Diseases. Die Arbeit nennt 52 Literaturangaben. Gefördert von: National Famous Elderly Chinese Medicine Experts Inheritance Workshop Construction Project of the National Administration of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Systemic inflammation plays a key role in the progression of osteoarthritis (OA). The aim of this study was to explore the association of an emerging systemic inflammation marker, the pan-immune-inflammation value (PIV), with all-cause and cardiovascular disease (CVD) mortality in patients with OA.

Methods

OA participants from the National Health and Nutrition Examination Survey 1999–2018 were included. PIV was calculated according to the following formula: PIV = (platelet count × neutrophil count × monocyte count)/lymphocyte count. OA was assessed through self-report, and mortality was obtained by matching to the National Death Index.

Results

A total of 3903 participants with OA were included. During the follow-up period, 1032 individuals died, 359 of whom died of CVD. After adjusting for all confounders, lnPIV was positively associated with all-cause and CVD mortality in the OA population (HR 1.273 and 1.364, respectively; P = .002 and P = .004). Participants with PIV at Q4 had a significantly increased risk of mortality compared to Q1 (HR 1.439 and 1.506, respectively). These associations all demonstrated nonlinear relationships and were significant only after the inflexion point, suggesting a threshold effect rather than a bidirectional pattern. Alcohol consumption influenced the association between PIV and CVD mortality. However, receiver operating characteristic analyses demonstrated the limited predictive value of PIV for long-term mortality.

Conclusions

Higher PIV was associated with increased risk of all-cause and CVD mortality in US adults with OA. High-quality studies are needed to explore the value of PIV in clinical mortality prediction models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoarthritisInflammationCardiovascular DiseasesHumansMaleFemaleMiddle AgedAgedRisk FactorsBiomarkersNutrition Surveys

Stichwörter der Autor:innen

NHANESSystemic inflammationmortalityosteoarthritispan-immune-inflammation value

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Liaoning University of Traditional Chinese Medicine, The Second Clinical College, Shenyang, China.
  • The Second Affiliated Hospital of Liaoning University of Chinese Medicine, Department of Orthopedics, Shenyang, China.

ORCID-Profile: Shixuan Wang

Förderung

  • National Famous Elderly Chinese Medicine Experts Inheritance Workshop Construction Project of the National Administration of Traditional Chinese Medicine

Zitieren

APA

Wang, D., Li, F., Liu, Y., & Wang, S. (2026). Association between pan-immune-inflammation value and mortality in osteoarthritis: evidence for elevated risk at higher levels. Modern Rheumatology, 36(6), 1055-1065. https://doi.org/10.1093/mr/roag038

Vancouver

Wang D, Li F, Liu Y, Wang S. Association between pan-immune-inflammation value and mortality in osteoarthritis: evidence for elevated risk at higher levels. Modern Rheumatology. 2026;36(6):1055-1065. doi:10.1093/mr/roag038

BibTeX
@article{Wang2026,
  author = {Wang, Donghai and Li, Fang and Liu, Yantong and Wang, Shixuan},
  title = {Association between pan-immune-inflammation value and mortality in osteoarthritis: evidence for elevated risk at higher levels},
  journal = {Modern Rheumatology},
  year = {2026},
  volume = {36},
  number = {6},
  pages = {1055--1065},
  doi = {10.1093/mr/roag038}
}
Kostenlos starten →